Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Toxicology"
DOI: 10.1080/15563650.2017.1357824
Abstract: Abstract Background: SGLT2 inhibitors are a new class of oral antidiabetics prescribed in the United States since 2013. They act by inhibiting reabsorption of glucose in the proximal convoluted tubule of the kidney, allowing excess…
read more here.
Keywords:
sglt2 inhibitors;
review sglt2;
poison centers;
sglt2 ... See more keywords